Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry

Prostate

Volumn 71, Issue 10, 2011, Pages 1054-1063

  Okobia, Michael N ^a,b   Zmuda, Joseph M ^a   Ferrell, Robert E ^a   Patrick, Alan L ^a,c   Bunker, Clareann H ^a,b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c Tobago Health Studies Office   (Trinidad and Tobago)

Author keywords

Afro Caribbean men; germline variations; Tobago prostate survey

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; CHROMOSOME 8Q; CHROMOSOME 8Q24; CONTROLLED STUDY; DNA ISOLATION; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHROMOSOMES, HUMAN, PAIR 8; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; TRINIDAD AND TOBAGO;

EID: 79955873729     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21320     Document Type: Article

References (32)

1. American Cancer Society. Cancer Facts and Figures 2009. Atlanta, GA: National Home Office. American Cancer Society, Inc.; 2009.
2. Bunker CH, Patrick AL, Konety BR, Dhir R, Brufsky AM, Vivas CA, Becich MJ, Trump DL, Kuller LH,. High prevalence of screening-detected prostate cancer among Afro-Caribbeans: The Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev 2002; 11 (8): 726-729. (Pubitemid 34851906)
3. Bunker CH, Patrick AL, Maharaj G, Keenan HA, Ramnarine S, Belle A, Richard JR, Dhir R,. Prostate cancer risk is three-fold higher among men, aged 50-64, of African descent compared with men of Asian-Indian descent in Trinidad and Tobago. Ethn Dis 2002; 12 (4): S3-30-33.
4. Chinegwundoh F, Enver M, Lee A, Nargund V, Oliver T, Ben-Shlomo Y,. Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in North-east London. BJU Int 2006; 98 (6): 1216-1220. (Pubitemid 44721227)
5. Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, Corbishley C, Dorling D, Thomas B, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Metcalfe C, Persad R,. The risk of prostate cancer amongst black men in the United Kingdom: The PROCESS cohort study. Eur Urol 2008; 53 (1): 99-105. (Pubitemid 350166704)
6. Glover FE Jr, Coffey DS, Douglas LL, Cadogan M, Russell H, Tulloch T, Baker TD, Wan RL, Walsh PC,. The epidemiology of prostate cancer in Jamaica. J Urol 1998; 159 (6): 1984-1986; discussion 1986-1987.
7. Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, Reams RR, Freedman ML, Rivers B, Green BL, Kumar N,. Prostate cancer disparities in Black men of African descent: A comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer 2009; 4 (Suppl 1): S2.
8. Witte JS,. Multiple prostate cancer risk variants on 8q24. Nat Genet 2007; 39 (5): 579-580. (Pubitemid 46676095)
9. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, Jakobsdottir M, Kostic J, Magnusdottir DN, Ghosh S, Agnarsson K, Birgisdottir B, Le Roux L, Olafsdottir A, Blondal T, Andresdottir M, Gretarsdottir OS, Bergthorsson JT, Gudbjartsson D, Gylfason A, Thorleifsson G, Manolescu A, Kristjansson K, Geirsson G, Isaksson H, Douglas J, Johansson JE, Balter K, Wiklund F, Montie JE, Yu X, Suarez BK, Ober C, Cooney KA, Gronberg H, Catalona WJ, Einarsson GV, Barkardottir RB, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K,. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006; 38 (6): 652-658. (Pubitemid 43927306)
10. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM, Oakley-Girvan I, Whittemore AS, Cooney KA, Ingles SA, Altshuler D, Henderson BE, Reich D,. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA 2006; 103 (38): 14068-14073. (Pubitemid 44452981)
11. Miljkovic-Gacic I, Ferrell RE, Patrick AL, Kammerer CM, Bunker CH,. Estimates of African, European and Native American ancestry in Afro-Caribbean men on the island of Tobago. Hum Hered 2005; 60 (3): 129-133. (Pubitemid 43130418)
12. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, Rafnar T, Bergthorsson JT, Agnarsson BA, Baker A, Sigurdsson A, Benediktsdottir KR, Jakobsdottir M, Xu J, Blondal T, Kostic J, Sun J, Ghosh S, Stacey SN, Mouy M, Saemundsdottir J, Backman VM, Kristjansson K, Tres A, Partin AW, Albers-Akkers MT, Godino-Ivan Marcos J, Walsh PC, Swinkels DW, Navarrete S, Isaacs SD, Aben KK, Graif T, Cashy J, Ruiz-Echarri M, Wiley KE, Suarez BK, Witjes JA, Frigge M, Ober C, Jonsson E, Einarsson GV, Mayordomo JI, Kiemeney LA, Isaacs WB, Catalona WJ, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K,. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007; 39 (5): 631-637. (Pubitemid 46676102)
13. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hunter DJ, Chanock SJ, Thomas G,. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39 (5): 645-649. (Pubitemid 46676108)
14. Robbins C, Torres JB, Hooker S, Bonilla C, Hernandez W, Candreva A, Ahaghotu C, Kittles R, Carpten J,. Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res 2007; 17 (12): 1717-1722. (Pubitemid 351359995)
15. Cheng I, Plummer SJ, Jorgenson E, Liu X, Rybicki BA, Casey G, Witte JS,. 8q24 and prostate cancer: Association with advanced disease and meta-analysis. Eur J Hum Genet 2008; 16 (4): 496-505. (Pubitemid 351420383)
16. Salinas CA, Kwon E, Carlson CS, Koopmeiners JS, Feng Z, Karyadi DM, Ostrander EA, Stanford JL,. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17 (5): 1203-1213.
17. Gohagan JK, Prorok PC, Hayes RB, Kramer BS,. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status. Control Clin Trials 2000; 21 (Suppl 6): 251S-272S.
18. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK,. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000; 21 (Suppl 6): 273S-309S.
19. Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, Feigelson HS, Thun MJ,. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: Rationale, study design, and baseline characteristics. Cancer 2002; 94 (9): 2490-2501. (Pubitemid 34457132)
20. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ,. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 2005; 65 (24): 11771-11778. (Pubitemid 41821739)
21. Valeri A, Briollais L, Azzouzi R, Fournier G, Mangin P, Berthon P, Cussenot O, Demenais F,. Segregation analysis of prostate cancer in France: Evidence for autosomal dominant inheritance and residual brother-brother dependence. Ann Hum Genet 2003; 67 (Pt 2): 125-137. (Pubitemid 38312819)
22. Heinonen OP, Huttunen JK, Albanes D, Haapakoski J, Palmgren J, Pietinen P, Pikkaarainen J, Rautalahti M, Virtamo J, Edwards BK, Greenwald P, Hartman A, Taylor PR, Haukka J, Jarvinen P, Malila N, Rapola S,. The alpha-tocopherol, beta-carotene lung cancer prevention study: Design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol 1994; 4 (1): 1-10. (Pubitemid 24102333)
23. van Duin M, van Marion R, Vissers K, Watson JE, van Weerden WM, Schroder FH, Hop WC, van der Kwast TH, Collins C, van Dekken H,. High-resolution array comparative genomic hybridization of chromosome arm 8q: Evaluation of genetic progression markers for prostate cancer. Genes Chromosomes Cancer 2005; 44 (4): 438-449. (Pubitemid 41476795)
24. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP,. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995; 55 (2): 342-347.
25. Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R, Thomas GV, Sawyers CL,. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 2003; 4 (3): 223-238. (Pubitemid 37163836)
26. Williams K, Fernandez S, Stien X, Ishii K, Love HD, Lau YF, Roberts RL, Hayward SW,. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Prostate 2005; 63 (4): 369-384. (Pubitemid 40664349)
27. Ferber MJ, Thorland EC, Brink AA, Rapp AK, Phillips LA, McGovern R, Gostout BS, Cheung TH, Chung TK, Fu WY, Smith DI,. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 2003; 22 (46): 7233-7242. (Pubitemid 37378556)
28. Ferber MJ, Eilers P, Schuuring E, Fenton JA, Fleuren GJ, Kenter G, Szuhai K, Smith DI, Raap AK, Brink AA,. Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13. Cancer Genet Cytogenet 2004; 154 (1): 1-9. (Pubitemid 39286165)
29. Taylor ML, Mainous AG III, Wells BJ,. Prostate cancer and sexually transmitted diseases: A meta-analysis. Fam Med 2005; 37 (7): 506-512. (Pubitemid 40967713)
30. Baudis M, Cleary ML,. Progenetix.net: An online repository for molecular cytogenetic aberration data. Bioinformatics 2001; 17 (12): 1228-1229. (Pubitemid 33735351)
31. Jia L, Landan G, Pomerantz M, Jaschek R, Herman P, Reich D, Yan C, Khalid O, Kantoff P, Oh W, Manak JR, Berman BP, Henderson BE, Frenkel B, Haiman CA, Freedman M, Tanay A, Coetzee GA,. Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet 2009; 5 (8): e1000597.
32. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, Le Marchand L, Kolonel LN, Frasco M, Wong D, Pooler LC, Ardlie K, Oakley-Girvan I, Whittemore AS, Cooney KA, John EM, Ingles SA, Altshuler D, Henderson BE, Reich D,. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007; 39 (5): 638-644. (Pubitemid 46676106)